Dr Bianca Ogden is a global healthcare investor and molecular biologist with more than two decades of experience in Funds Management, managing the global health sciences strategy at Platinum Asset Management. As an investor Bianca combines deep scientific expertise with rigorous commercial and valuation analysis. A key investment focus are next generation therapies, often investing early in the development journey. Prior to investment management, she conducted antiviral research at Novartis and oncology drug discovery at Johnson & Johnson. She holds a Master of Biology from the University of Tübingen and a PhD in Virology from University College London.